SUBCUTANEOUS T-CELL LYMPHOMA TREATED WITH SYSTEMIC CHEMOTHERAPY, AUTOLOGOUS STEM-CELL SUPPORT, AND LIMB AMPUTATION

Citation
Cl. Haycox et al., SUBCUTANEOUS T-CELL LYMPHOMA TREATED WITH SYSTEMIC CHEMOTHERAPY, AUTOLOGOUS STEM-CELL SUPPORT, AND LIMB AMPUTATION, Journal of the American Academy of Dermatology, 37(5), 1997, pp. 832-835
Citations number
15
Categorie Soggetti
Dermatology & Venereal Diseases
ISSN journal
01909622
Volume
37
Issue
5
Year of publication
1997
Part
2
Supplement
S
Pages
832 - 835
Database
ISI
SICI code
0190-9622(1997)37:5<832:STLTWS>2.0.ZU;2-J
Abstract
Subcutaneous T-cell lymphoma is an unusual variant of peripheral T-cel l lymphoma in which the malignant infiltrate preferentially involves t he subcutis. The disease is often initially misdiagnosed as a benign i nflammatory panniculitis or a granulomatous disease, We describe subcu taneous T-cell lymphoma in a 39-year-old man who was treated with syst emic chemotherapy, autologous stem cell support, and amputation of the limb primarily involved with the lymphomatous infiltrate. This is the first report of amputation being included in the treatment regimen of subcutaneous T-cell lymphoma. Because preferential involvement of the extremities often occurs in patients with subcutaneous T-cell lymphom a, surgical debulking of refractory disease by partial or complete lim b amputation may be a useful therapeutic adjunct.